As one of five facilities designated by the U.S. Centers for Disease Control and Prevention (CDC) to serve as a regional training and medical consultation center, Mayo Clinic Center for Tuberculosis is committed to providing comprehensive resources to prevent, control and treat tuberculosis (TB). Read more
With CDC guidance, and in coordinated partnership with other regional centers and national entities, Mayo Clinic offers:
With CDC guidance, and in coordinated partnership with other regional centers and national entities, Mayo Clinic offers:
- Highest-quality, multidisciplinary expertise to assist in the diagnosis, treatment and prevention of TB
World TB Day - March 24
In preparing for World TB Day on March 24, the Centers for Disease Control and Prevention’s Division of Tuberculosis Elimination (CDC/DTBE) is pleased to announce additional 2017 World TB Day communication messages and materials that are now available on their website. Materials include:
NTCA National TB Conference
"Culture of Collaboration" is the theme for the 2017 NTCA National TB Conference. This conference is an annual forum that brings state, local, territorial, and other TB control professionals together to discuss a wide array of clinical, technical, policy, and programmatic TB issues.
This conference will be held on April 18-21 in Atlanta, Georgia, with special meetings on April 18 and post-meetings in the afternoon on Friday, April 21.
Some key topics include:
View Draft Agenda
Registration Now Open for The Mycobacteriology Laboratory Webinar
Topic: The Mycobacteriology Laboratory: Tests, Results, and Clinical Implications
Date: March 17, 2017
Time: 12:00 noon (Central Daylight Time)
A free webinar (400 seats) is being offered by the National TB Nurse Coalition, the nursing section of the National TB Controllers Association (NTCA). 1.2 CEUs are available for nurses. Speakers include:
Registration URL: https://www.pathlms.com/tbcontrollers/courses/4259/
Round Robin Held in Oakland, CA
March 7, 2017
On February 27 and 28, a Round Robin was hosted by the Curry International Tuberculosis Center in Oakland, California. All five RTMCCs, along with representatives from the CDC were present. Dr. Temesgen and Jennifer Curran attended from the Mayo Center for Tuberculosis.
Development of Sutezolid for TB Treatment
January 25, 2017
Johns Hopkins University and the Medicines Patient Pool (MPP) have signed a license agreement to facilitate the clinical development of the tuberculosis drug, sutezolid. Sutezolid, an oxazolidinone antibiotic in the same class as linezolid, has shown promise in use as a compound in early stage trials to be more potent and less toxic in the treatment of TB.
Now Available in Spanish - Modules 6 and 8 of the CDC's Self-Study Modules on Tuberculosis
January 18, 2017
The CDC has recently published Modules 6 and 8 of the Self-Study Modules in Spanish. These Self-Study Modules on Tuberculosis are a series of educational modules designed to provide information about TB in a self-study format. The series consists of a total of nine modules that are separated into two courses. The first course, Modules 1-5, provides basic information on TB. The second course, Modules 6-9, provides more specific TB programmatic information.
WHO Establishes Global TB Research Task Force
December 21, 2016
The goal toward ending TB by 2030 moved another step forward with the creation of a task force comprised of experts from both academia and TB programs as well as finance who will work together to drive forward the goal to improve TB care and control. The team will also contribute to the preparation of the WHO Ministerial Conference on TB, to be held in Moscow on November 16-17, 2017.
DTBE Partners with Medscape
December 19, 2016
The Centers for Disease Control and Prevention’s Division of Tuberculosis Elimination (DTBE) has partnered with Medscape, a leading online resource for physicians and healthcare professionals, to produce an expert video commentary featuring DTBE Director, Dr. Philip LoBue. The video provides information for physicians on the new U.S. Preventive Services Task Force recommendation for latent TB infection testing. Dr. LoBue discusses diagnosis and treatment guidelines, as well as available DTBE resources on latent TB infection.
The video is a great way to share information with private healthcare providers on the importance of latent TB infection testing and treatment. You can find the video online: http://www.medscape.com/viewarticle/873121?src=par_cdc_stm_mscpedt&faf=1
World TB Day Announcement: Unite to End TB
December 16, 2016
World TB Day is recognized every March 24th with various activities across the world. The Division of Tuberculosis Elimination (DTBE) within the CDC announced the theme for 2017 events this week: Unite to End TB.
For more information about World TB Day events, including information about the 2017 U.S. TB Elimination Champions Project, or if you are planning an event in conjunction with the 2017 World TB Day, connect with the DTBE by clicking the link below.
WHO Welcomes UNGA Resolution on First-Ever High-level Meeting on TB in 2018.
Geneva, 15 December, 2016
The World Health Organization (WHO) welcomes the United Nations (UN) General Assembly (GA) Resolution A/71/L.41 passed today, calling for the UNGA to hold the first-ever high-level meeting on the fight against tuberculosis (TB) in 2018.
WHO has been asked to work with the UN Secretary-General, in consultation with Member States, to conceptualize and plan the 2018 high-level meeting. The resolution also highlights the WHO Global Ministerial Conference on the fight against TB in the context of public health Sustainable Development Goals, which will be hosted by the Russian Federation in Moscow on 16-17 November 2017.
“This is a tremendous and unprecedented step forward by governments and all partners engaged in the fight against TB”, said Dr Mario Raviglione, Director of the WHO Global TB Programme. “The Ministerial Conference and the UNGA high-level meeting will be fundamental to drive efforts to end this top infectious killer. We look forward to working closely with the Office of the UN Secretary-General, in consultation with Member States, to ensure the meeting results in bold and innovative solutions. For that, the engagement of all partners will be crucial for the success of these meetings.”
WHO in its report this year announced that TB was one of the top 10 causes of death worldwide in 2015, responsible for more deaths than HIV and malaria. In the same year, an estimated 1.8 million people died from TB, of which 0.4 million were co-infected with HIV. Worldwide, 10.4 million people fell ill with TB. The report highlighted the need for countries to move much faster to prevent, detect, and treat the disease if they are to meet global targets.
Newly Published: 2016 Clinical Practice Guidelines for Diagnosis of Tuberculosis in Adults and Children
December 9, 2016
Just released by the CDC, the American Thoracic Society, and the Infectious Diseases Society of America, these guidelines provide recommendations on the diagnosis of latent TB infection, pulmonary TB, and extrapulmonary TB in adults and children, updating guidelines that were published in 2000.
The guidelines provide evidence-based recommendations that were developed with the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) methodology. GRADE involves structured literature review, systematic reviews and meta-analyses of combined data, and expert discussion to assess the certainty in the evidence and determine the strength of each recommendation.
The twenty-three evidence-based recommendations include guidance for clinicians on how to employ newer tests to diagnose TB disease and latent TB infection, including interferon-gamma release assays (IGRAs) and molecular diagnostics. Although TB is less common in the United States than in other parts of the world, clinicians should consider testing patients who have a higher-risk for TB infection, including patients who were born in or who frequently travel to countries where TB disease is common; patients who live or have lived in large group settings, such as homeless shelters or prisons and jails; or those with other risk factors, as described in the guidelines.
Now Available Online from the CDC: Reported Tuberculosis in the United States, 2015
December 1, 2016
Earlier this year, the Centers for Disease Control and Prevention (CDC) released provisional 2015 surveillance data on reported tuberculosis (TB) cases in the United States. The full report, entitled Reported Tuberculosis in the United States, 2015, is now available online.
Treatment of Drug-Susceptible Tuberculosis Guidelines Webinar
November 28, 2016
View this webinar, 2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis, which highlights the guidelines development process, the key changes in recommendations and discussion of evidence supporting the changes. This 90-minute presentation is directed toward physicians, nurses and other health professionals who treat and case manage patients with active TB. Sponsored by the five RTMCCs, the presentation was aired on November 4.
Link to Webinar
McGill 2017 Summer Institute in Infectious Diseases and Global Health - Now Accepting Applications!
November 18, 2016
The McGill 2017 Summer Institute in Infectious Diseases and Global Health is now open with six courses. Courses include:
You are encouraged to apply early. The deadline for those needing a VISA for Canada is February 28, and registration closes on April 24.
Wisconsin Mycobacteria Laboratory Network (WMLN) Annual Conference
November 17, 2017
At the Wisconsin Mycobacteria Laboratory Network Annual Conference, Dr. Zelalem Temesgen of the Mayo Clinic Center for Tuberculosis discussed the topic of "Tuberculosis in the Setting of HIV Infection". To access the presentation, please click the link below.
Tuberculosis in the Setting of HIV Infection
Drug-Resistant TB: A Survival Guide for Clinicians, 3rd Edition Now Available
November 16, 2017
Curry International Tuberculosis Center has published the fully revised and updated third edition of the publication Drug-Resistant Tuberculosis: A Survival Guide for Clinicians. The guide is free and contains information and user-friendly tools and templates for use by any clinician who participates in the management of patients with drug-resistant TB. More Information
To order, click the image below.
Courses in the Pacific Islands
Mayo Clinic Center for Tuberculosis and the other RTMCCs are sponsoring five trainings in the Pacific Islands in 2017. Locations include Guam, Hawaii, and American Samoa. The first course is a Clinical Intensive course in Guam on March 22-24.
Medical consultation for complex cases is a core service of the Mayo Clinic Center for Tuberculosis.
Contact us about a consultation via:
Mayo Clinic Center for Tuberculosis Knowledge Base
The Mayo Clinic Center for Tuberculosis Knowledge Base is a web-based search tool containing expert clinical information on various topics related to tuberculosis. This resource is designed to help public health officials quickly find topic-specific information which has been vetted by Mayo Clinic tuberculosis consultants. In addition, users will find links to useful outside sources which provide additional information and related topics. More information.
Tuberculosis Management Resources for the Emergency Department
The Tuberculosis Management Resources for the Emergency Department resource provides access to a variety of tools that enable health professionals to quickly and easily find information about TB in an emergency department setting. It contains four major areas:
The Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
To coincide with World TB Day 2015, the Mayo Clinic Center for Tuberculosis has launched a new journal dedicated to provide a forum for clinically relevant articles on all aspects of tuberculosis and other mycobacterial infections. More Information
SUBMIT YOUR RESEARCH
TB eReview: DRTB
A new app has just been published in the iTunes store. Free of charge, this app is designed to stimulate effective learning in the diagnosis and management of drug-resistant tuberculosis.
Specific topics addressed include factors associated with drug resistance; clues in the medical history; diagnosis of drug-resistance both by conventional and molecular methods; selection of drugs for treatment of various degrees of drug resistant TB – mono, dual, multi-drug, and XDR; monitoring of patients on treatment for drug-resistant TB; and recognition of drug adverse events as well as drug interactions.
The interactive TB eReview DRTB app has 2 components or modes:
To access information about this app and to download, click the link below.
For optimal viewing, please use Google Chrome or Mozilla Firefox as your browser.